Stay updated on Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Vienna study sites are now listed with Completed status and specific postal codes; a Nouvelle-Aquitaine site (Pessac) was removed and a New Aquitaine site (Pessac) was added.
    Difference
    0.4%
    Check dated 2026-04-20T02:16:55.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site, Clinica Amo - Rio Vermelho in Salvador, Bahia (ID 231604), was added and marked as Completed on 2026-04-08, updating the ZIP code to 41950-640 and replacing the previous Recruiting entry at 41950-610.
    Difference
    0.1%
    Check dated 2026-04-13T01:08:15.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Gazi Universitesi (Ankara, Türkiye) as site 265425, bringing total locations to 316. Cross Cancer Institute (252065) and Asklepios Fachkliniken München-Gauting (272768) were added, updating the site count from 315 to 316.
    Difference
    0.1%
    Check dated 2026-03-22T04:33:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added Jeroen Bosch Ziekenhuis as a recruitment site in 's-Hertogenbosch, Netherlands (ID 234087); total locations updated to 315.
    Difference
    0.1%
    Check dated 2026-03-08T01:39:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-14T11:13:20.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, indicating a minor update to the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T06:58:23.000Z thumbnail image

Stay in the know with updates to Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.